Venous thromboembolism (VTE) prevention in cancer patients is a critical unmet need. For this initiative, ACCC examined the VTE protocols for cancer patients in both the inpatient and outpatient settings of care.
Caring for cancer patients who are at risk for VTE presents unique challenges for community-based cancer care providers. Identifying patients at risk for VTE is particularly challenging. Care coordination of at-risk patients across care settings is crucial.
ACCC captured several of the barriers to identifying cancer patients at risk of VTE and approaches to facilitate the identification of at-risk patients, as well as tools and resources to help ensure evaluations and identification occur.
ACCC conducted a multidisciplinary focus group and membership survey on how cancer programs manage patients at high risk for developing VTE.
This ACCC publication summarizes focus group findings and survey results, discusses potential issues around identifying and treating VTE, and identifies opportunities for improvement regarding outpatient VTE risk assessment, prophylaxis, and management in the community setting. Download it to learn more about best practices for patient education, patient monitoring, and identification of at-risk patients.
Support provided by
Janssen Pharmaceuticals, Inc.
ACCC is solely responsible for content.